Financhill
Back

Agenus Vs. Perspective Therapeutics Industry Stock Comparison

Sell
27

AGEN
Agenus

Last Price:
3.35
Seasonality Move:
3.12%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
27
Agenus (AGEN) is a Sell

Is Agenus a Buy, Sell or Hold?

  • The current Agenus [AGEN] share price is $3.34. The Score for AGEN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • AGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AGEN Stock Price Chart

What is Agenus's stock price today?

  • The Agenus share price today is $3.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

AGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 42.62 Sell
Chaikin Money Flow: 931523 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.05 - 4.45) Sell
Bollinger Bands (100): (2.61 - 9.43) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

AGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.82 Buy
20-day SMA: 3.57 Sell
50-day SMA: 4.45 Sell
200-day SMA: 9.28 Sell
8-day EMA: 3.02 Buy
20-day EMA: 3.45 Sell
50-day EMA: 4.4 Sell
200-day EMA: 9.49 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Agenus Earnings Growth & AGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $2.25 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Agenus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):